Company Filing History:
1 out of 1 
1 out of 1 
1 out of 1 Years Active: 2003-2005
Title: Adam Telerman: Innovator in Tumor Suppression and Behavioral Research
Introduction
Adam Telerman is a prominent inventor based in Paris, France. He has made significant contributions to the fields of molecular biology and therapeutic research. With a total of 4 patents, his work focuses on understanding the molecular pathways involved in tumor suppression and behavioral disorders.
Latest Patents
One of Adam Telerman's latest patents involves genes that play a crucial role in the molecular pathways of tumor suppression and resistance to viruses. This invention addresses the genes whose cell expression is particularly induced or inhibited during apoptosis and tumor suppression. Another notable patent describes the use of animal models deficient in p53, which exhibit memory deficiencies and behavioral disorders such as increased anxiety. This method outlines how p53-deficient mice can be utilized to screen compounds for memory-restoring and anti-anxiety activities.
Career Highlights
Throughout his career, Adam Telerman has worked with various organizations, including Société Molecular Engines Laboratories, a French Société Anonyme, and Molecular Engines Laboratories. His innovative research has positioned him as a key figure in the scientific community.
Collaborations
Adam has collaborated with notable individuals in his field, including Robert Amson and Daniel Cohen. Their combined expertise has contributed to advancements in understanding complex biological processes.
Conclusion
Adam Telerman's work in tumor suppression and behavioral research highlights his innovative spirit and dedication to scientific advancement. His contributions continue to influence the fields of molecular biology and therapeutic development.